M. Palous

429 total citations
9 papers, 305 citations indexed

About

M. Palous is a scholar working on Infectious Diseases, Epidemiology and Cell Biology. According to data from OpenAlex, M. Palous has authored 9 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Epidemiology and 3 papers in Cell Biology. Recurrent topics in M. Palous's work include Fungal Infections and Studies (7 papers), Antifungal resistance and susceptibility (7 papers) and Plant Pathogens and Fungal Diseases (3 papers). M. Palous is often cited by papers focused on Fungal Infections and Studies (7 papers), Antifungal resistance and susceptibility (7 papers) and Plant Pathogens and Fungal Diseases (3 papers). M. Palous collaborates with scholars based in France, Singapore and Switzerland. M. Palous's co-authors include Arnaud Fekkar, I. Meyer, Jean‐Yves Brossas, Dominique Mazier, A. Datry, Sébastien Imbert, Christophe Hennequin, Madalina Uzunov, Éric Dannaoui and Jean‐Louis Golmard and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

M. Palous

9 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Palous France 8 222 202 85 76 32 9 305
Adriana Lopes Motta Brazil 12 358 1.6× 336 1.7× 57 0.7× 98 1.3× 30 0.9× 21 437
Liliana Guelfand Argentina 10 306 1.4× 295 1.5× 34 0.4× 66 0.9× 24 0.8× 39 399
Inaam Al‐Obaid Kuwait 12 337 1.5× 256 1.3× 69 0.8× 39 0.5× 34 1.1× 19 410
Christina Henderson United States 9 165 0.7× 201 1.0× 114 1.3× 113 1.5× 46 1.4× 13 374
C. Rennison United Kingdom 3 314 1.4× 271 1.3× 39 0.5× 39 0.5× 20 0.6× 5 367
Min Ji Choi South Korea 13 454 2.0× 381 1.9× 65 0.8× 94 1.2× 38 1.2× 28 546
Daniel F. Sheehan United States 6 279 1.3× 242 1.2× 34 0.4× 44 0.6× 17 0.5× 11 363
Marco Passera Italy 10 189 0.9× 186 0.9× 46 0.5× 74 1.0× 14 0.4× 16 276
Bram Spruijtenburg Netherlands 12 380 1.7× 305 1.5× 25 0.3× 95 1.3× 33 1.0× 52 448
Dolores Pinheiro Portugal 10 212 1.0× 132 0.7× 20 0.2× 106 1.4× 62 1.9× 20 313

Countries citing papers authored by M. Palous

Since Specialization
Citations

This map shows the geographic impact of M. Palous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Palous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Palous more than expected).

Fields of papers citing papers by M. Palous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Palous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Palous. The network helps show where M. Palous may publish in the future.

Co-authorship network of co-authors of M. Palous

This figure shows the co-authorship network connecting the top 25 collaborators of M. Palous. A scholar is included among the top collaborators of M. Palous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Palous. M. Palous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Imbert, Sébastien, Anne‐Cécile Normand, Sophie Cassaing, et al.. (2020). Multicentric Analysis of the Species Distribution and Antifungal Susceptibility of Cryptic Isolates from Aspergillus Section Fumigati. Antimicrobial Agents and Chemotherapy. 64(12). 26 indexed citations
2.
Imbert, Sébastien, I. Meyer, M. Palous, et al.. (2018). Aspergillus PCR in Bronchoalveolar Lavage Fluid for the Diagnosis and Prognosis of Aspergillosis in Patients With Hematological and Non-hematological Conditions. Frontiers in Microbiology. 9. 1877–1877. 28 indexed citations
3.
Imbert, Sébastien, et al.. (2017). Performance of Aspergillus PCR in cerebrospinal fluid for the diagnosis of cerebral aspergillosis. Clinical Microbiology and Infection. 23(11). 889.e1–889.e4. 30 indexed citations
4.
Imbert, Sébastien, Antoni Pons, I. Meyer, et al.. (2016). Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia. Clinical Microbiology and Infection. 22(10). 891.e5–891.e8. 14 indexed citations
5.
Imbert, Sébastien, Lauraine Gauthier, M. Palous, et al.. (2015). Performances de la PCR Aspergillus sur sérum pour le diagnostic des aspergilloses invasives. Journal de Mycologie Médicale. 25(3). 220–220. 1 indexed citations
6.
Lescar, Julien, I. Meyer, Chandra Verma, et al.. (2014). Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole. Journal of Antimicrobial Chemotherapy. 69(12). 3244–3247. 39 indexed citations
7.
Imbert, Sébastien, M. Palous, I. Meyer, et al.. (2014). In Vitro Combination of Voriconazole and Miltefosine against Clinically Relevant Molds. Antimicrobial Agents and Chemotherapy. 58(11). 6996–6998. 27 indexed citations
8.
Fekkar, Arnaud, I. Meyer, Jean‐Yves Brossas, et al.. (2013). Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin. Antimicrobial Agents and Chemotherapy. 57(5). 2380–2382. 45 indexed citations
9.
Marinach, Carine, Alexandre Alanio, M. Palous, et al.. (2009). MALDI‐TOF MS‐based drug susceptibility testing of pathogens: The example of Candida albicans and fluconazole. PROTEOMICS. 9(20). 4627–4631. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026